This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Winning in Life Sciences

Navigating a complex industry

Winning in Life Sciences

In this post-recession era, many global health systems will be impacted by a series of austerity measures. Pricing and re-imbursement pressures, high hurdles for innovation, and the need to demonstrate economic value can only get more severe. Patent expiry, and the lack of new products coming to market, means that life sciences companies will struggle to deliver top-line growth. Companies have re-structured their commercial models to meet the demands of the mature health markets and to focus on value and market access.

Stay connected
Get connected
Share your comments